EP2797429 - STABILIZED CONCENTRATED LIQUID HUMAN MILK FORTIFIER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.12.2016 Database last updated on 27.07.2024 | Most recent event Tooltip | 16.12.2016 | Application deemed to be withdrawn | published on 18.01.2017 [2017/03] | Applicant(s) | For all designated states ABBOTT LABORATORIES 100 Abbott Park Road Abbott Park, IL 60064-3500 / US | [2014/45] | Inventor(s) | 01 /
VURMA, Mustafa 10214 Archer Lane Dublin, OH 43017 / US | 02 /
KONUKLAR, Gul 4514 Commons Park Drive New Albany, OH 43054 / US | [2014/45] | Representative(s) | Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | [N/P] |
Former [2014/45] | Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road London WC1X 8BT / GB | Application number, filing date | 12799473.9 | 03.12.2012 | WO2012US67589 | Priority number, date | US201161581634P | 30.12.2011 Original published format: US 201161581634 P | [2014/45] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013101401 | Date: | 04.07.2013 | Language: | EN | [2013/27] | Type: | A1 Application with search report | No.: | EP2797429 | Date: | 05.11.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.07.2013 takes the place of the publication of the European patent application. | [2014/45] | Search report(s) | International search report - published on: | EP | 04.07.2013 | Classification | IPC: | A23L1/0522, A23L1/29, A23L1/305 | [2014/45] | CPC: |
A23L29/219 (EP,US);
A23L33/17 (CN);
A23C9/206 (US);
A23C9/152 (US);
A23C9/1526 (US);
A23L29/212 (CN);
A23L33/125 (CN);
A23L33/18 (EP,US);
A23L33/40 (EP,US);
A23V2002/00 (CN)
(-)
| C-Set: |
A23V2002/00, A23V2200/222, A23V2200/30 (CN)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/45] | Title | German: | STABILER, KONZENTRIERTER UND FLÜSSIGER VERSTÄRKER FÜR MENSCHLICHE MILCH | [2014/45] | English: | STABILIZED CONCENTRATED LIQUID HUMAN MILK FORTIFIER | [2014/45] | French: | FORTIFIANT POUR LAIT HUMAIN LIQUIDE CONCENTRÉ STABILISÉ | [2014/45] | Entry into regional phase | 27.05.2014 | National basic fee paid | 27.05.2014 | Designation fee(s) paid | 27.05.2014 | Examination fee paid | Examination procedure | 27.05.2014 | Examination requested [2014/45] | 26.02.2015 | Amendment by applicant (claims and/or description) | 01.04.2016 | Despatch of a communication from the examining division (Time limit: M04) | 12.08.2016 | Application deemed to be withdrawn, date of legal effect [2017/03] | 12.09.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/03] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.04.2016 | Fees paid | Renewal fee | 05.12.2014 | Renewal fee patent year 03 | 07.12.2015 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]EP0189161 (ABBOTT LAB [US]) [Y] 1-10 * the whole document *; | [A]US6077558 (EUBER JOHN [US]) [A] 1-15 * the whole document *; | [A]WO2008014041 (BRISTOL MYERS SQUIBB CO [US], et al) [A] 1-15 * the whole document *; | [Y]WO2009079002 (CARGILL INC [US], et al) [Y] 1-10 * the whole document *; | [AP]WO2012061242 (ABBOTT LAB [US], et al) [AP] 1-15* the whole document * | by applicant | US6096358 | US6227261 | US6371319 | - KLEINMAN ET AL., "Use of infant formulas in infants with cow milk allergy: a review and recommendations", PEDIATR ALLERGY IMMUNOL, (1991), vol. 4, pages 146 - 155 |